Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GRATIFII LIMITED Proxy Solicitation & Information Statement 2021

Apr 8, 2021

65023_rns_2021-04-08_2caea5d6-550f-49a9-902f-38722bce7def.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

MOBECOM LIMITED

ACN 125 688 940

NOTICE OF GENERAL MEETING

TIME : 4 pm (AEST)

DATE : Tuesday 11[th] May 2021

PLACE : Novus Capital, Level 11, 95 Pitt Street, New South Wales, 2000

This Notice of Meeting should be read in its entirety. Shareholders in doubt as to how they should vote should seek advice from their professional advisers prior to voting.

Should you wish to discuss the matters in this Notice of Meeting please do not hesitate to contact the company secretary on 1300 288 664.

Legal/74543857_36

CONTENTS PAGE

Business of the Meeting (setting out the proposed resolutions) 5
Explanatory Statement (explaining the proposed resolutions) 13
Glossary 37
Proxy Form Annexure 1
Terms of Plan Options Annexure 2
Material Terms of the IOP Annexure 3
Total Dilution Annexure 4
IMPORTANT INFORMATION

TIME AND PLACE OF MEETING

Notice is hereby given that a General Meeting of Shareholders of Mobecom Limited ( Company or Mobecom ) will be held at the offices of Novus Capital on 11[th] May 2021, at 4pm (AEST).

The Explanatory Statement that accompanies and forms part of this Notice of Meeting sets out the background information on the various matters to be considered. The Proxy Form also forms part of this Notice of Meeting.

This Notice of Meeting, Explanatory Statement and Proxy Form should be read in their entirety.

YOUR VOTE IS IMPORTANT

The business of the Meeting affects your shareholding and your vote is important.

VOTING ELIGIBILITY

The Directors have determined pursuant to regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that the persons eligible to vote at the Meeting are those who are registered Shareholders of the Company as at 7pm (AEST) on 7[th] May 2021.

VOTING IN PERSON

To vote in person, attend the Meeting at the time, date and place set out above.

VOTING BY PROXY

To vote by proxy, please complete and sign the enclosed/attached Proxy Form and return by the time, and in accordance with the instructions, set out on the Proxy Form.

In accordance with section 249L of the Corporations Act, Shareholders are advised that: • each Shareholder has a right to appoint a proxy;

2

Legal/74543857_36

  • the proxy need not be a Shareholder of the Company; and

  • a Shareholder who is entitled to cast 2 or more votes may appoint 2 proxies and may specify the proportion or number of votes each proxy is appointed to exercise. If the Shareholder appoints 2 proxies and the appointment does not specify the proportion or number of the Shareholder’s votes, then in accordance with section 249X(3) of the Corporations Act, each proxy may exercise one-half of the votes.

A proxy may be an individual or a body corporate. If a body corporate is appointed, the proxy form must indicate the full name of the body corporate and the full name and title of the individual representative of the body corporate for the Meeting.

A Proxy Form accompanies this notice. If a Shareholder wishes to appoint more than 1 proxy, they may make a copy of the Proxy Form attached to this Notice. For the Proxy Form to be valid it must be received together with the power of attorney or other authority (if any) under which the form is signed, or a (notarially) certified copy of that power or authority.

Sections 250BB and 250BC of the Corporations Act apply to voting by proxy. Broadly, these provisions provide that:

  • if proxy holders vote, they must cast all directed proxies as directed; and

  • any directed proxies which are not voted will automatically default to the Chair, who must vote the proxies as directed.

Further details are set out below.

Proxy vote if appointment specifies way to vote

Section 250BB(1) of the Corporations Act provides that an appointment of a proxy may specify the way the proxy is to vote on a particular resolution and, if it does :

  • the proxy need not vote on a show of hands, but if the proxy does so, the proxy must vote that way (i.e. as directed);

  • if the proxy has 2 or more appointments that specify different ways to vote on the resolution, the proxy must not vote on a show of hands;

  • if the proxy is the Chair of the meeting at which the resolution is voted on, the proxy must vote on a poll, and must vote that way (i.e. as directed); and

  • if the proxy is not the Chair – the proxy need not vote on the poll, but if the proxy does so, the proxy must vote that way (i.e. as directed).

Transfer of non-chair proxy to Chair in certain circumstances

Section 250BC of the Corporations Act provides that, if:

  • an appointment of a proxy specifies the way the proxy is to vote on a particular resolution at a meeting of the company's shareholders;

  • the appointed proxy is not the Chair of the meeting;

  • at the meeting, a poll is duly demanded on the resolution; and

3

Legal/74543857_36

  • either of the following applies:

  • the proxy is not recorded as attending the meeting; and

  • the proxy does not vote on the resolution,

the Chair of the meeting is taken, before voting on the resolution closes, to have been appointed as the proxy for the purposes of voting on the resolution at that meeting.

Proxy Voting by the Chair

The Corporations Act imposes prohibitions on Key Management Personnel and their Closely Related Parties from voting their shares (and/or voting undirected proxies) on, amongst other things, remuneration matters.

However, the Chair of a meeting may vote an undirected proxy (i.e. a proxy that does not specify how it is to be voted), provided the shareholder who has lodged the proxy has given an express voting direction to the Chair to exercise the undirected proxy, even if the resolution is connected with the remuneration of a member of Key Management Personnel.

If you complete a Proxy Form that authorises the Chair of the Meeting to vote on your behalf as proxy, and you do not mark any of the boxes so as to give him directions about how your vote should be cast, then you will be taken to have expressly authorised the Chair to exercise your proxy on the Resolution. In accordance with this express authority provided by you, the Chair will vote in favour of the Resolution. If you wish to appoint the Chair of the Meeting as your proxy, and you wish to direct him how to vote, please tick the appropriate boxes on the Proxy Form.

CORPORATE REPRESENTATIVES

Any corporation which is a Shareholder of the Company may appoint a proxy, as set out above, or authorise (by certificate under common seal or other form of execution authorised by the laws of that corporation’s place of incorporation, or in any other manner satisfactory to the Chair) a natural person to act as its representative at any general meeting.

Corporate representatives are requested to bring appropriate evidence of appointment as a representative in accordance with the Constitution. Attorneys are requested to bring an original or certified copy of the power of attorney pursuant to which they were appointed. Proof of identity is also required for corporate representatives and attorneys.

4

Legal/74543857_36

BUSINESS OF THE MEETING

1. RESOLUTION 1: CHANGE OF COMPANY NAME

To consider and, if thought fit, to pass with or without amendment, the following Resolution as a special resolution :

“That, in accordance with section 157(1) of the Corporations Act, and for all other purposes, the Company change its name from "Mobecom Limited" to "Gratifii Limited."

2. RESOLUTION 2: APPROVAL FOR ISSUE OF SHARES TO MR IAIN DUNSTAN

To consider and, if thought fit, to pass with or without amendment, the following Resolution as an ordinary resolution :

  • “That, for the purposes of ASX Listing Rule 10.11 and for all other purposes, Shareholders approve the issue of 5,000,000 Shares at an issue price of $0.02 per Share to Mr Iain Dunstan on the terms and conditions set out in the Explanatory Statement."

Voting Exclusion: The Company will disregard any votes cast in favour of this Resolution 2 by or on behalf of Mr Dunstan and any other person who will obtain a material benefit as a result of the issue of Securities (except a benefit solely by reason of being a Shareholder) and any of their associates.

However, this does not apply to a vote cast in favour of this Resolution by:

  • (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way;

  • (b) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (c) a Shareholder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • (i) the beneficiary provides written confirmation to the Shareholder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

  • (ii) the Shareholder votes on the Resolution in accordance with directions given by the beneficiary to the Shareholder to vote in that way.

3. RESOLUTION 3: APPROVAL FOR ISSUE OF SHARES TO MR BRYAN ZEKULICH

To consider and, if thought fit, to pass with or without amendment, the following Resolution as an ordinary resolution :

  • “That, for the purposes of ASX Listing Rule 10.11 and for all other purposes, Shareholders approve the issue of 5,000,000 Shares at an issue price of $0.02 per Share to Mr Bryan Zekulich, on the terms and conditions set out in the Explanatory Statement."

5

Legal/74543857_36

Voting Exclusion: The Company will disregard any votes cast in favour of this Resolution 3 by or on behalf of Mr Zekulich and any other person who will obtain a material benefit as a result of the issue of Securities (except a benefit solely by reason of being a Shareholder) and any of their associates.

However, this does not apply to a vote cast in favour of this Resolution by:

  • (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way;

  • (b) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (c) a Shareholder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • (i) the beneficiary provides written confirmation to the Shareholder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

  • (ii) the Shareholder votes on the Resolution in accordance with directions given by the beneficiary to the Shareholder to vote in that way.

4. RESOLUTION 4: APPROVAL FOR ISSUE OF SHARES TO MR MICHAEL HILL

To consider and, if thought fit, to pass with or without amendment, the following Resolution as an ordinary resolution :

"That, for the purposes of ASX Listing Rule 10.11and for all other purposes, Shareholders approve the issue of 2,500,000 Shares at an issue price of $0.02 per Share to Mr Michael Hill on the terms and conditions set out in the Explanatory Statement."

Voting Exclusion: The Company will disregard any votes cast in favour of this Resolution 4 by or on behalf of Mr Hill and any other person who will obtain a material benefit as a result of the issue of Securities (except a benefit solely by reason of being a Shareholder) and any of their associates.

However, this does not apply to a vote cast in favour of this Resolution by:

  • (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way;

  • (b) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (c) a Shareholder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • (i) the beneficiary provides written confirmation to the Shareholder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

6

Legal/74543857_36

(ii)

the Shareholder votes on the Resolution in accordance with directions given by the beneficiary to the Shareholder to vote in that way.

5. RESOLUTION 5: APPROVAL OF ISSUE OF CONVERTIBLE NOTES TO BOMBORA

To consider and, if thought fit, to pass, with or without amendment, the following Resolution as an ordinary resolution :

“That, for the purposes of ASX Listing Rule 7.1 and for all other purposes, 10 Convertible Notes at a subscription price of $150,000 each, be issued to Bombora in satisfaction of the Company's obligations to repay the Bombora Loan on the terms and conditions set out in the Explanatory Statement."

Voting Exclusion: The Company will disregard any votes cast in favour of this Resolution 5 by or on behalf of Bombora or any person who will obtain a material benefit as a result of the proposed issue of Securities (except a benefit solely by reason of being a Shareholder) and any of their associates.

However, this does not apply to a vote cast in favour of this Resolution by:

  • (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way;

  • (b) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (c) a Shareholder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • (i) the beneficiary provides written confirmation to the Shareholder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

  • (ii) the Shareholder votes on the Resolution in accordance with directions given by the beneficiary to the Shareholder to vote in that way.

6. RESOLUTION 6: APPROVAL FOR ISSUE OF SHARES TO NOVUS CAPITAL

To consider and, if thought fit, to pass with or without amendment, the following Resolution as an ordinary resolution :

“That, for the purposes of ASX Listing Rule 7.1 and for all other purposes, Shareholders approve the issue of 12,000,000 Shares at a deemed issue price of $0.02 per Share to Novus Capital on the terms and conditions set out in the Explanatory Statement."

Voting Exclusion: The Company will disregard any votes cast in favour of this Resolution 6 by or on behalf of Novus Capital and any other person who will obtain a material benefit as a result of the issue of Securities (except a benefit solely by reason of being a Shareholder) and any of their associates.

However, this does not apply to a vote cast in favour of this Resolution by:

7

Legal/74543857_36

  • (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way;

  • (b) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (c) a Shareholder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • (i) the beneficiary provides written confirmation to the Shareholder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

  • (ii) the Shareholder votes on the Resolution in accordance with directions given by the beneficiary to the Shareholder to vote in that way.

7. RESOLUTION 7: APPROVAL FOR PROPOSED ISSUE OF SHARES TO BOMBORA

To consider and, if thought fit, to pass with or without amendment, the following Resolution as an ordinary resolution :

"That, for the purposes of ASX Listing Rule 7.1 and for all other purposes, Shareholders approve the proposed issue of 4,000,000 Shares at a deemed issue price of $0.02 per Share to Bombora on the terms and conditions set out in the Explanatory Statement."

Voting Exclusion: The Company will disregard any votes cast in favour of this Resolution 7 by or on behalf of Bombora and any other person who will obtain a material benefit as a result of the proposed issue of Securities (except a benefit solely by reason of being a Shareholder) and any of their associates.

However, this does not apply to a vote cast in favour of this Resolution by:

  • (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way;

  • (b) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (c) a Shareholder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • (i) the beneficiary provides written confirmation to the Shareholder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

  • (ii) the Shareholder votes on the Resolution in accordance with directions given by the beneficiary to the Shareholder to vote in that way.

8

Legal/74543857_36

8. RESOLUTION 8: APPROVAL FOR PROPOSED ISSUE OF SHARES TO MR NEIL JOSEPH IN LIEU OF UNPAID DIRECTORS FEES

To consider and, if thought fit, to pass with or without amendment, the following Resolution as an ordinary resolution :

“That, for the purposes of ASX Listing Rule 7.1 and for all other purposes, Shareholders approve the proposed issue of 5,791,000 Shares at a deemed issue price of $0.04 per Share in lieu of unpaid Directors fees owed to Mr Neil Joseph by the Company, on the terms and conditions set out in the Explanatory Statement."

Voting Exclusion: The Company will disregard any votes cast in favour of this Resolution 8 by or on behalf of Mr Joseph and any other person who will obtain a material benefit as a result of the proposed issue of Securities (except a benefit solely by reason of being a Shareholder) and any of their associates.

However, this does not apply to a vote cast in favour of this Resolution by:

  • (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way;

  • (b) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (c) a Shareholder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • (i) the beneficiary provides written confirmation to the Shareholder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

  • (ii) the Shareholder votes on the Resolution in accordance with directions given by the beneficiary to the Shareholder to vote in that way.

9. RESOLUTION 9: PROPOSED ISSUE OF PLAN OPTIONS TO MR IAIN DUNSTAN

To consider and, if thought fit, to pass, with or without amendment, the following Resolution as an ordinary resolution :

“That, for the purposes of ASX Listing Rule 10.14 and for all other purposes, Shareholders approve the proposed issue of 5,555,104 Plan Options to Mr Iain Dunstan on the terms and conditions set out in the Explanatory Statement."

Voting Exclusion: The Company will disregard any votes cast in favour of this Resolution 9 by or on behalf of a person referred to in ASX Listing Rule 10.14.1, 10.14.2 or 10.14.3 (including Mr Dunstan) who is eligible to participate in the employee incentive scheme and any associate of those persons.

However, this does not apply to a vote cast in favour of this Resolution by:

  • (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way;

9

Legal/74543857_36

  • (b) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (c) a Shareholder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • (i) the beneficiary provides written confirmation to the Shareholder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

  • (ii) the Shareholder votes on the Resolution in accordance with directions given by the beneficiary to the Shareholder to vote in that way.

10. RESOLUTION 10: PROPOSED ISSUE OF PLAN OPTIONS TO MR CHRISTOPHER JOSEPH

To consider and, if thought fit, to pass, with or without amendment, the following Resolution as an ordinary resolution :

  • “That, for the purposes of ASX Listing Rule 10.14 and for all other purposes, Shareholders approve the proposed issue of 1,388,776 Plan Options to Mr Christopher Joseph on the terms and conditions set out in the Explanatory Statement."

Voting Exclusion: The Company will disregard any votes cast in favour of this Resolution 10 by or on behalf of a person referred to in ASX Listing Rule 10.14.1, 10.14.2 or 10.14.3 (including Mr Joseph) who is eligible to participate in the employee incentive scheme and any associate of those persons.

However, this does not apply to a vote cast in favour of this Resolution by:

  • (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way;

  • (b) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (c) a Shareholder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • (i) the beneficiary provides written confirmation to the Shareholder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

  • (ii) the Shareholder votes on the Resolution in accordance with directions given by the beneficiary to the Shareholder to vote in that way.

11. RESOLUTION 11: PROPOSED ISSUE OF PLAN OPTIONS TO MR BRYAN ZEKULICH

To consider and, if thought fit, to pass, with or without amendment, the following Resolution as an ordinary resolution :

10

Legal/74543857_36

“That, for the purposes of ASX Listing Rule 10.14 and for all other purposes, Shareholders approve the proposed issue of 1,500,000 Plan Options to Mr Bryan Zekulich on the terms and conditions set out in the Explanatory Statement."

Voting Exclusion: The Company will disregard any votes cast in favour of this Resolution 11 by or on behalf of a person referred to in ASX Listing Rule 10.14.1, 10.14.2 or 10.14.3 (including Mr Zekulich) who is eligible to participate in the employee incentive scheme and any associate of those persons.

However, this does not apply to a vote cast in favour of this Resolution by:

  • (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way;

  • (b) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (c) a Shareholder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • (i) the beneficiary provides written confirmation to the Shareholder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

  • (ii) the Shareholder votes on the Resolution in accordance with directions given by the beneficiary to the Shareholder to vote in that way.

12. RESOLUTION 12: PROPOSED ISSUE OF PLAN OPTIONS TO MR MICHAEL HILL

  • To consider and, if thought fit, to pass, with or without amendment, the following Resolution as an ordinary resolution :

“That, for the purposes of ASX Listing Rule 10.14 and for all other purposes, Shareholders approve the proposed issue of 1,500,000 Plan Options to Mr Michael Hill on the terms and conditions set out in the Explanatory Statement."

Voting Exclusion: The Company will disregard any votes cast in favour of this Resolution 12 by or on behalf of a person referred to in ASX Listing Rule 10.14.1, 10.14.2 or 10.14.3 (including Mr Hill) who is eligible to participate in the employee incentive scheme and any associate of those persons.

However, this does not apply to a vote cast in favour of this Resolution by:

  • (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way;

  • (b) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (c) a Shareholder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

11

Legal/74543857_36

  • (i) the beneficiary provides written confirmation to the Shareholder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

  • (ii) the Shareholder votes on the Resolution in accordance with directions given by the beneficiary to the Shareholder to vote in that way.

13. RESOLUTION 13: APPROVAL FOR ISSUE OF SHARES TO CHRISTOPHER LAWRANCE UPON CONVERSION OF DEBT

To consider and, if thought fit, to pass with or without amendment, the following Resolution as an ordinary resolution :

“That, for the purposes of ASX Listing Rule 7.1 and for all other purposes, Shareholders approve the proposed issue of 9,000,000 Shares to Christopher Lawrance at a deemed issue price of $0.027 upon conversion of debt owed by the Company on the terms and conditions set out in the Explanatory Statement."

Voting Exclusion: The Company will disregard any votes cast in favour of this Resolution 13 by or on behalf of Mr Lawrance and any other person who will obtain a material benefit as a result of the proposed issue of Securities (except a benefit solely by reason of being a Shareholder) and any of their associates.

However, this does not apply to a vote cast in favour of this Resolution by:

  • (a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way;

  • (b) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (c) a Shareholder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • (i) the beneficiary provides written confirmation to the Shareholder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

  • (ii) the Shareholder votes on the Resolution in accordance with directions given by the beneficiary to the Shareholder to vote in that way.

DATED: 9 APRIL 2021

BY ORDER OF THE BOARD

DAVID HWANG

COMPANY SECRETARY

12

Legal/74543857_36

EXPLANATORY STATEMENT

This Explanatory Statement has been prepared to provide information which the Directors believe to be material to Shareholders deciding whether or not to pass the Resolutions which are the subject of the business of the Meeting.

1. RESOLUTION 1: CHANGE OF COMPANY NAME

1.1 Background

Resolution 1 is a special resolution which seeks approval of the Shareholders for the Company to change its name. Subject to the Resolution being passed, the Company proposes to change its name from "Mobecom Limited" to "Gratifii Limited". The change will not, in itself, affect the legal status of the Company or any of its assets or liabilities.

The Company wishes to change its name to better reflect the renewed focus on its core loyalty and rewards business having now exited all other non-core businesses.

1.2 Approval under section 157 of the Corporations Act

In accordance with section 157 of the Corporations Act, Shareholder approval by special resolution is required. As a result, 75% of the votes cast by Shareholders present and eligible to vote (in person or by proxy) at the Meeting must be in favour of the Resolution for it to be passed.

Subject to Shareholder approval, the Company will make an application to ASIC for the change of name to "Gratifii Limited". The new name will take effect on the issue of a certificate of registration of change of name by ASIC.

If this Resolution is not passed, the Company's name will not be changed to Gratifii Limited.

If the Resolution is approved by Shareholders, the Company is proposing to seek to change its ASX code to GTI.

1.3 Board recommendation

The Board recommends that Shareholders vote in favour of Resolution 1.

2. RESOLUTION 2: APPROVAL FOR ISSUE OF SHARES TO MR IAIN DUNSTAN

2.1 Background

Mr Dunstan is the Company's Executive Chairman. In support of the Company's operations and future development Mr Dunstan wishes to subscribe for 5,000,000 Shares at a price of $0.02 per Share to raise $100,000. This is the price at which shares were issued in the $4,000,000 placement which completed on 14 January 2021.

As at the date of this Notice, Mr Dunstan and his Associates hold 787,491 Shares and 13,256,195 Options, 5,325,284 of which are Plan Options.

2.2 Approval for the purposes of ASX Listing Rule 10.11 is sought

ASX Listing Rule 10.11.1 requires a listed entity to obtain Shareholder approval by ordinary resolution prior to the issue of, or agreement to issue, Securities to a person who is a Related

13

Legal/74543857_36

Party. Mr Dunstan is a Director and the current Executive Chairman of the Company. As a result, Mr Dunstan is a Related Party and falls within the category set out in ASX Listing Rule 10.11.1.

Accordingly, this Resolution 2 seeks Shareholder approval for the issue of 5,000,000 Shares to Mr Dunstan pursuant to ASX Listing Rule 10.11. If this Resolution is not passed, the Company will not be able to raise $100,000 from the subscription of Shares by Mr Dunstan. To understand the effect of passing this Resolution, please see Annexure 4.

2.3 Approval for the purposes of Chapter 2E of the Corporations Act not sought

For a public company, or an entity that a public company controls, to give a financial benefit to a Related Party of the public company, the public company or entity must:

  • (a) obtain the approval of the public company's members in the manner set out in sections 221 to 227 of the Corporations Act; and

  • (b) give the benefit within 15 months following such approval,

unless the giving of the financial benefit falls within an exception set out in sections 210 to 216 of the Corporations Act.

A 'financial benefit' for the purposes of the Corporations Act has a wide meaning and catches the issue of the Shares to Mr Dunstan. Consequently, the issue of the Shares the subject of this Resolution 2 will, for the purposes of Chapter 2E of the Corporations Act, constitute giving a financial benefit to a Related Party of the Company.

As recently as 14 January 2021 (please refer to the announcement dated that date), the Company has placed Shares with sophisticated and professional investors on the same terms as the issue of Shares to Mr Dunstan which are the subject of this Resolution 2. It is therefore the Directors' view that the giving of the financial benefit to Mr Dunstan as a Related Party of the Company is on arm's length and falls within the exception in section 210 of the Corporations Act.

Accordingly, Shareholder approval for the purposes of Chapter 2E is not being sought.

2.4 Shareholder approval under ASX Listing Rule 7.1 not sought

Exception 14 to ASX Listing Rule 7.2 provides that if Shareholder approval for a transaction is being obtained pursuant to ASX Listing Rule 10.11, approval is not required under ASX Listing Rule 7.1. Therefore, Shareholder approval is not being sought for the approval of this Resolution.

2.5 Required information

Pursuant to ASX Listing Rule 10.13 the following information is provided.

Person to whom the Securities are to
be issued, number and class
Mr Dunstan is to be issued 5,000,000
Shares. Mr Dunstan is a Related Party
of the Company as he is a Director.
Issue date The Shares will be issued within one
month after the date of this Meeting.
Issue price $0.02 per Share.

14

Legal/74543857_36

Terms of the Securities Shares will rank equally in all respects
with the existing fully paid ordinary
Shares.
Purpose of issue and use of funds $100,000 will be received by the
Company for the issue of Shares to Mr
Dunstan. These funds will be applied
towards
the
Company's
ongoing
operations and development.
Material terms of agreement Nil.

2.6 Board recommendation

The Board recommends, with Mr Dunstan abstaining, that Shareholders vote in favour of this Resolution 2.

3. RESOLUTION 3: APPROVAL FOR ISSUE OF SHARES TO MR BRYAN ZEKULICH

3.1 Background

Mr Zekulich was appointed a Director of the Company on 29 December 2020. He wishes to support the Company's future development by subscribing for 5,000,000 Shares at a price of $0.02 per Share to raise $100,000.

As at the date of this Notice, Mr Zekulich and his Associates hold nil Shares and nil Options in the Company.

3.2 Approval for the purposes of ASX Listing Rule 10.11 is sought

ASX Listing Rule 10.11 requires a listed entity to obtain Shareholder approval by ordinary resolution prior to the issue, or agreement to issue, of Securities to a Related Party as stated more fully in section 2.2. Since Mr Zekulich is also a Director, he is considered a Related Party of the Company and accordingly, approval under ASX Listing Rule 10.11 is being sought as Mr Zekulich falls within the category under ASX Listing Rule 10.11.1. If Shareholders do not approve this Resolution, no Shares will be issued to Mr Zekulich and $100,000 will not be raised by the Company from Mr Zekulich. To understand the effect of passing this Resolution, please see Annexure 4.

3.3 Approval for the purposes of Chapter 2E of the Corporations Act not sought

We refer to section 2.3 which summarises the Company's obligations under Chapter 2E of the Corporations Act.

As the Company has recently placed Shares with sophisticated and professional investors on the same terms as the issue of Shares to Mr Zekulich which are the subject of this Resolution 3, the Directors are of the view that the giving of the financial benefit to Mr Zekulich as a Related Party of the Company falls within the arm's length exception in section 210 of the Corporations Act.

Accordingly, Shareholder approval for the purposes of Chapter 2E is not being sought.

15

Legal/74543857_36

3.4 Shareholder approval under ASX Listing Rule 7.1 not sought

Exception 14 to ASX Listing Rule 7.2 provides that if Shareholder approval for a transaction is being obtained pursuant to ASX Listing Rule 10.11, approval is not required under ASX Listing Rule 7.1. Therefore, Shareholder approval is not being sought for the approval of this Resolution.

3.5

Required information

Pursuant to ASX Listing Rule 10.13 the following information is provided.

Person to whom the Securities are to
be issued, number and class
Mr Zekulich is to be issued 5,000,000
Shares. Mr Zekulich is a Related Party of
the Company as he is a Director.
Issue date The Shares will be issued within one
month after the date of this Meeting.
Issue price $0.02 per Share.
Terms of the Securities The Shares will rank equally in all
respects with the existing fully paid
ordinary Shares.
Purpose of issue and use of funds $100,000 will be received by the
Company for the issue of Shares to Mr
Zekulich. These funds will be applied
towards
the
Company's
ongoing
operations and development.
Material terms of agreement Nil.

3.6 Board recommendation

The Board recommends, with Mr Zekulich abstaining, that Shareholders vote in favour of Resolution 3.

4. RESOLUTION 4: APPROVAL FOR ISSUE OF SHARES TO MR MICHAEL HILL

4.1 Background

Mr Hill became a Director of the Company on 29 December 2020. To support the Company's ongoing development Mr Hill intends to subscribe for 2,500,000 Shares at a price of $0.02 per Share to raise $50,000.

As at the date of this Notice, Mr Hill and his Associates hold nil Shares and nil Options in the Company.

4.2 Approval for the purposes of ASX Listing Rule 10.11 is sought

ASX Listing Rule 10.11 requires a listed entity to obtain Shareholder approval by ordinary resolution prior to the issue, or agreement to issue, of Securities to a Related Party as more fully described in section 2.2. Similarly as a Director, Mr Hill is considered a Related Party of the

16

Legal/74543857_36

Company and accordingly, approval under ASX Listing Rule 10.11 is being sought as Mr Hill falls within the category under ASX Listing Rule 10.11.1. If Shareholders do not approve this Resolution, no Shares will be issued to Mr Hill and $50,000 will not be raised from Mr Hill. To understand the effect of passing this Resolution, please see Annexure 4.

4.3 Approval for the purposes of Chapter 2E of the Corporations Act not sought

We refer to section 2.3 which summarises the Company's obligations under Chapter 2E of the Corporations Act.

As the Company has recently placed Shares with sophisticated and professional investors on the same terms as the issue of Shares to Mr Hill the subject of this Resolution 4, the Directors are of the view that the giving of the financial benefit to Mr Hill as a Related Party of the Company, falls within the arm's length exception in section 210 of the Corporations Act.

4.4 Shareholder approval under ASX Listing Rule 7.1 not sought

Exception 14 to ASX Listing Rule 7.2 provides that if Shareholder approval for a transaction is being obtained pursuant to ASX Listing Rule 10.11, approval is not required under ASX Listing Rule 7.1. Therefore, Shareholder approval is not being sought for the approval of this Resolution.

4.5

Required information

Pursuant to ASX Listing Rule 10.13 the following information is provided.

Person to whom the Securities are to
be issued, number and class
Mr Hill is to be issued 2,500,000 Shares. Mr
Hill is a Related Party of the Company as
he is a Director.
Issue date The Shares will be issued within one
month after the date of this Meeting.
Issue price $0.02 per Share.
Terms of the Securities The Shares will rank equally in all
respects with the existing fully paid
ordinary Shares.
Purpose of issue and use of funds $50,000
will
be
received
by
the
Company for the issue of Shares to Mr
Hill. These funds will be applied towards
the Company's ongoing operations and
development.
Material terms of agreement Nil.

4.6 Board recommendation

The Board recommends, with Mr Hill abstaining, that Shareholders vote in favour of Resolution 4.

17

Legal/74543857_36

5. RESOLUTION 5: APPROVAL OF PROPOSED ISSUE OF CONVERTIBLE NOTES

5.1 Bombora Loan Agreement and General Security Deed

On 24 February 2021 the Company entered into a loan agreement with Bombora ( Bombora Loan Agreement ). The Company intends to use these borrowed funds to improve its operations and invest in its future development. The key terms of the Bombora Loan Agreement are as follows:

Term Three months, being from 24 February
2021 to 24 May 2021.
Principal $1,500,000.
Interest rate 8% p. a. accruing daily.
Repayment conditions The Bombora Loan must be repaid
within the term either in cleared funds
or via the issue of Convertible Notes.
Default interest rate 18% p.a. default interest applies upon
an event of default.
Material Events of Default Failure
to
convene
this
General
Meeting
to
obtain
Shareholder
approval for this Resolution to issue
Convertible Notes.
An insolvency event occurs.
Failure to repay the Bombora Loan by
the end of the term.
Security General
security
deed
between
Bombora
(as
grantee)
and
the
Company (as grantor) dated 24
February 2021 (GSD).

The key terms of the GSD are as follows:

Secured Property All of the Company's present and
future assets and rights as well as the
Company's present and future rights
and interests in any asset.
Priority The security interest granted under the
GSD takes priority over all other security
interests granted by the Company.
Discharge Bombora must discharge and release
its security interest under the GSD once
the Bombora Loan has been paid in full
and the Company has discharged its

18

Legal/74543857_36

obligations under the GSD and Bombora Loan Agreement.

==> picture [205 x 39] intentionally omitted <==

5.2 Convertible Note Agreement

The Company proposes to repay the Bombora Loan by issuing 10 Convertible Notes to Bombora at a subscription price of $150,000 per Convertible Note ( Convertible Note Agreement ).

The full terms of the Convertible Note Agreement are available in the Appendix of the Company's 25 February 2021 announcement. The key terms of the Convertible Note Agreement between Bombora and the Company are as follows:

Number of Convertible Notes and
face value
10 Convertible Notes with a face value
of $150,000.
Conversion price The Convertible Notes will convert into
Shares by dividing the face value and
accrued interest by $0.02 per Share.
Interest rate 8% p.a. will accrue daily on the face
value from the date of the Bombora
Loan Agreement.
Maturity date 24 months after the date of the
Bombora Loan Agreement, i.e. 24
February 2023.
Conditions precedent The parties' obligations under the
Convertible Note Agreement will be
subject to Shareholders approving this
Resolution to issue the proposed
Convertible Notes.
Conversion The Convertible Notes are convertible
into Shares at Bombora's option any
time up to the maturity date or a
takeover event occurring.
The Convertible Notes are convertible
into Shares at the Company's option
on the earlier of the maturity date or a
takeover event.
Redemption The Convertible Notes may only be
redeemed upon an event of default
(i.e., an insolvency event or a failure to
pay any money owing under the
Convertible Note Agreement).

19

Legal/74543857_36

Transferability and rights The Convertible Notes are transferable
and do not entitle Bombora to any
voting rights.
Reorganisation of capital Upon any bonus issue or reorganisation
of Share capital, the number of Shares
which may be issued to Bombora
under
the
Convertible
Note
Agreement will be adjusted to ensure
that Bombora receives the same
proportion of Shares as it would
otherwise have received had the
bonus issue or reorganisation not
occurred.

5.3 Approval for the purposes of ASX Listing Rule 7.1 is sought

As announced on 26 November 2020, the Company has provided an undertaking to the ASX that it will not issue any Equity Securities without Shareholder approval until 13 December 2021, unless the issue of Equity Securities falls within an exception set out in ASX Listing Rule 7.2. Accordingly, Shareholder approval is sought to approve the issue of the abovementioned Convertible Notes.

The effect of such approval is that the Company will be entitled to issue the Convertible Notes to Bombora. This will allow the Company to repay the Bombora Loan through the issue of Convertible Notes. To understand the effect of passing this Resolution, please see Annexure 4.

Shares issued on the conversion of the Convertible Notes will fall within ASX Listing Rule 7.2 exception 9 and will not require further Shareholder approval.

If this Resolution is not passed, the Company will not be able to issue Convertible Notes in satisfaction of its obligation to repay the Bombora Loan. As a result, the Company would be obliged to repay the Bombora Loan from its cash reserves or otherwise raise additional equity capital (subject to Shareholder approval) to fund the repayment of the Bombora Loan in accordance with its terms.

5.4 Required information

Pursuant to ASX Listing Rule 7.3 the following information is provided.

Person(s) to whom the Securities
were issued
Bombora.
Number and class of Securities 10 Convertible Notes.
Issue date of Securities The Convertible Notes will be issued
within three months after the date of this
Meeting.
Issue price of Securities $150,000 per Convertible Note.

20

Legal/74543857_36

Purpose of issue and use of funds No funds will be received upon issuing
the
Convertible
Notes,
rather
the
Convertible Note will be issued to repay
the Bombora Loan without drawing
down on the Company's cash reserves.
Terms of Securities Upon conversion of the Convertible
Notes into Shares, those Shares will rank
equally in all respects with the existing
fully paid ordinary Shares.
Summary of material terms of
agreement
Please see section 5.2.

5.5 Board recommendation

The Board recommends, with Mr Zekulich and Mr Hill abstaining, that Shareholders vote in favour of Resolution 5.

6. RESOLUTION 6: APPROVAL FOR ISSUE OF SHARES TO NOVUS CAPITAL

6.1 Background

As announced on 17 August 2020 and further discussed as Resolution 10 of the Company's 27 November 2020 general meeting, the Company engaged Novus Capital to raise capital under the Company's most recent $4,000,000 placement which was successfully completed on 14 January 2021 ( Novus Mandate ). In part consideration for Novus Capital's services and in accordance with its obligations under the Novus Mandate, the Company has agreed, subject to obtaining Shareholder approval, to issue 12,000,000 Shares valued at a deemed issue price of $0.02 per Share to Novus Capital ( Novus Shares ).

6.2 Approval for the purposes of ASX Listing Rule 7.1 is sought

As announced on 26 November 2020, the Company has provided an undertaking to the ASX that it will not issue any Equity Securities without Shareholder approval until 13 December 2021, unless the issue of Equity Securities falls within an exception set out in ASX Listing Rule 7.2.

Accordingly, Shareholder approval is sought to approve the issue of Novus Shares to Novus Capital. The effect of such approval is that the Company will be entitled to issue the Novus Shares to Novus Capital. This will allow the Company to meet its obligations to Novus Capital through Shares. To understand the effect of passing this Resolution, please see Annexure 4.

If this Resolution 6 is not passed and the Company does not obtain Shareholder approval to issue the Novus Shares, the Company will be obliged to pay Novus Capital the cash equivalent of the value of the issue, i.e. $240,000.

6.3 Required information

Pursuant to ASX Listing Rule 7.3 the following information is provided.

21

Legal/74543857_36

Person to whom the Securities are to
be issued, number and class
Novus
Capital
is
to
be
issued
12,000,000 Novus Shares.
Issue date The Novus Shares will be issued to
Novus Capital within three months
after the date of this Meeting (or such
later date to the extent permitted by
any ASX waiver or modification to the
Listing Rules).
Issue price $0.02 per Novus Share.
Terms of the Securities Each Novus Share will rank equally in
all respects with the existing fully paid
ordinary Shares.
Purpose of issue and use of funds No funds will be raised by this issue,
however the issue of Shares to Novus
Capital will ensure the Company is
not obliged to pay Novus Capital the
equivalent value of the Shares in cash
and
thereby
depleting
the
Company's cash reserves.
Material terms of agreement The material terms of the Novus
Mandate include that:
• Novus Capital will use its best
endeavours to raise a minimum of
$3,000,000 and a maximum of
$4,000,000 at $0.02 per Share from
sophisticated
and
professional
investors
• nominated external investors must
contribute
an
additional
$1,200,000 as a part of the
minimum $3,000,000 or maximum
of $4,000,000 capital raise
• Novus Capital's engagement will
continue until completion of the
capital raise, unless terminated
earlier
• Novus Capital will be entitled to
receive the following fees:
o
engagement and financial
advisory fee of $50,000;
o
legal fee capped at $20,000;

22

Legal/74543857_36

==> picture [197 x 444] intentionally omitted <==

o management fee of 1% of all
capital raised;
o brokerage fee of 5% of all
capital raised;
o success fee of:

5,000,000 Shares for raising
$1,500,000 at $0.02 per
Share;

up to 5,000,0000 Shares for
raising $2,500,000 or more
(prorated
if
between
$1,500,000 to $2,500,000 is
raised) at $0.02 per Share;
and

2,000,000 Shares for raising
$4,000,000 at $0,02 per
Share
these amounts were raised
and the payment of this
success fee is the 12,000,000
Novus Shares the subject of
this Resolution; and
o reimbursement
of
out
of
pocket expenses.
Novus Shares will be voluntarily
escrowed for 6 months.

6.4 Board recommendation

The Board recommends that Shareholders vote in favour of this Resolution 6.

7. RESOLUTION 7: APPROVAL FOR PROPOSED ISSUE OF SHARES TO BOMBORA

7.1 Background

Bombora are an investment management fund focused on sourcing and executing early growth stage opportunities. On 22 December 2020 Bombora agreed to invest:

  • (a) $480,000 of capital through the issue of 24,000,000 Shares at $0.02 per Share; and

  • (b) $1,500,000 of capital in connection with an issue of Convertible Notes as described at section 5,

  • ( Bombora Investment Commitment ). The $480,000 capital raise formed a part of the $4,000,000 capital raise which was successfully completed on 14 January 2021 and announced to the market on the same date.

23

Legal/74543857_36

In part consideration for Bombora's investment and in accordance with its obligations under the Bombora Investment Commitment, the Company intends, subject to obtaining Shareholder approval, to issue 4,000,000 Shares valued at a deemed issue price of $0.02 per shareto Bombora ( Bombora Shares ). Bombora requires 4,000,000 Shares in recognition of the risk of its additional investment.

7.2 Approval for the purposes of the ASX Listing Rule is sought

As announced on 26 November 2020, the Company has provided an undertaking to the ASX that it will not issue any Equity Securities without Shareholder approval until 13 December 2021, unless the issue of Equity Securities falls within an exception set out in ASX Listing Rule 7.2.

Accordingly, Shareholder approval is sought to approve the proposed issue of Bombora Shares to Bombora. The effect of such approval is that the Company will be entitled to issue the Bombora Shares To understand the effect of passing this Resolution, please see Annexure 4.

If this Resolution 7 is not passed and the Company does not obtain Shareholder approval to issue the Bombora Shares, the Company will be obliged to pay Bombora the cash equivalent of the value of the proposed issue, i.e. $80,000.

7.3

Required information

Pursuant to ASX Listing Rule 7.3 the following information is provided.

Person to whom the Securities are to
be issued, number and class
Bombora is to be issued 4,000,000
Bombora Shares.
Issue date The Bombora Shares will be issued to
Bombora within three months after the
date of this Meeting (or such later date
to the extent permitted by any ASX
waiver or modification to the Listing
Rules).
Issue price $0.02 per Bombora Share.
Terms of the Securities Each Bombora Share will rank equally
in all respects with the existing fully
paid ordinary Shares.
Purpose of issue and use of funds No funds will be raised by this issue
however the issue of Shares to
Bombora will ensure the Company is
not obliged to pay Bombora the cash
equivalent value of the Shares and
thereby deplete the Company's cash
reserves.
Material terms of agreement The material terms of the Bombora
Investment Commitment include that:
• Bombora will invest $480,000 in the
Companytoreceive Shares at

24

Legal/74543857_36

==> picture [206 x 458] intentionally omitted <==

==> picture [201 x 458] intentionally omitted <==

----- Start of picture text -----

$0.02 per Share (this investment was
made in January 2021)
• Bombora will contribute $1,500,000
to the Company on the terms of the
Loan Agreement and Convertible
Note Agreement (summarised
above at 5.1 and 5.2)

Mr Zekulich and Mr Hill will join the
board as a non-executive Directors
• Bombora will be entitled to receive
the following consideration:
o if this Resolution is approved,
the Bombora Shares
calculated on the basis of 1
additional Share for each 6
Shares allotted to Bombora as
a part of its $480,000
investment; or
o if this Resolution is not
approved, the value of the
Bombora Shares ($80,000) in
cash; and
o 6% brokerage fee on the total
number of Shares allotted
($480,000 worth) payable on
re-listing.
Bombora Shares will be voluntarily
escrowed for 6 months.
----- End of picture text -----

7.4 Board recommendation

The Board recommends, with Mr Zekulich and Mr Hill abstaining, that Shareholders vote in favour of this Resolution 7.

8. RESOLUTION 8: APPROVAL FOR PROPOSED ISSUE OF SHARES TO MR NEIL JOSEPH IN LIEU OF UNPAID DIRECTOR FEES

8.1 Background

Mr Joseph is currently owed $351,000 in fees for his prior tenure as a Director of the Company. The Company has agreed to issue Shares to Mr Joseph in lieu of the outstanding director fees. Approval to issue Shares to Mr Joseph will allow the Company to apply those funds, which would otherwise be applied to the outstanding director fees, to its commercial operations.

Shares to be issued to Mr Joseph in lieu of outstanding director fees have been determined based on:

25

Legal/74543857_36

  • (a) the amount of director fees owed to Mr Joseph and are issued in lieu of cash payments; and

  • (b) a deemed issue price of $0.04.

Mr Joseph is owed a total of $351,000 in outstanding director fees. Therefore, upon approval of this Resolution 8, 5,791,000 Shares will be issued to Mr Joseph in lieu of the outstanding director fees owed to him.

8.2 Mr Neil Joseph not considered a Related Party

As stated in section 8.1 above, Mr Joseph served as a Director of the Company until 15 October 2019. Accordingly, Mr Joseph was considered a Related Party of the Company until the date that is 6 months following the cessation of his appointment, i.e. until 15 April 2020. As this date has passed Mr Joseph is no longer considered a Related Party of the Company.

8.3 Approval for the purposes of ASX Listing Rule 7.1 is sought

As announced on 26 November 2020, the Company has provided an undertaking to the ASX that it will not issue any Equity Securities without Shareholder approval until 13 December 2021, unless the issue of Equity Securities falls within an exception set out in ASX Listing Rule 7.2.

Accordingly, Shareholder approval is sought to approve the issue of Securities to Mr Joseph. The effect of such approval is that the Company will be entitled to issue 5,791,000 Shares to Mr Joseph. To understand the effect of passing this Resolution, please see Annexure 4.

If this Resolution 8 is not approved, the Company must draw down its cash reserve to pay Mr Joseph's remuneration .

8.4 Required information

Pursuant to ASX Listing Rule 7.3 the following information is provided.

Person to whom the Securities are to
be issued, number and class
Mr Joseph is to be issued 5,791,000
Shares in lieu of unpaid director fees.
Issue date The Shares will be issued to Mr Joseph
within three months after the date of
this Meeting.
Issue price $0.04 per Share.
Terms of the Securities Shares will rank equally in all respects
with the existing fully paid ordinary
Shares.
Purpose of issue and use of funds No funds will be received by the
Company for the issue of Shares to Mr
Joseph however the issue will set off
the obligation of the Company to pay
Mr Joseph his unpaid remuneration in
cash.

26

Legal/74543857_36

Remuneration package and terms of
appointment
Pursuant
to
the
terms
of
his
appointment, Mr Joseph was entitled
to
receive
an
annual
salary
of
$175,000.

8.5 Board recommendation

The Board recommends that Shareholders vote in favour of this Resolution 8.

9. RESOLUTION 9: PROPOSED ISSUE OF PLAN OPTIONS TO MR IAIN DUNSTAN

9.1 Background

The Company's employee incentive scheme was first adopted by Shareholders on 1 May 2017 and recently renewed for a further 3 years at the Company's general meeting of 27 November 2020 ( Incentive Option Plan or IOP ). The IOP was established to help achieve the Company's corporate objectives by attracting and retaining its key staff through incentives.

As a Director and the Executive Chairman, Mr Dunstan is eligible to participate in the IOP. In recognition of Mr Dunstan's performance and to further promote Mr Dunstan's engagement with Mobecom, the Company proposes, subject to obtaining Shareholder approval, to issue 5,555,104 Plan Options to Mr Dunstan. For the avoidance of doubt, no consideration is payable by Mr Dunstan to receive the Plan Options.

As at the date of this Notice, Mr Dunstan and his Associates hold 787,491 Shares, 13,930,911 Options and 5,325,284 Plan Options in the Company. If Resolution 2 is passed, Mr Dunstan and his Associates will hold 5,787,491 Shares and 13,930,911 Options and 5,325,284 Plan Options in the Company.

9.2 Approval for the purposes of ASX Listing Rule 10.14 is sought

ASX Listing Rule 10.14.1 requires a listed entity to obtain Shareholder approval by ordinary resolution prior to the issue of, or agreement to issue, Securities under an employee incentive scheme to a person who is a Related Party. As a Director and the current Executive Chairman of the Company, Mr Dunstan is a Related Party falling within the category set out in ASX Listing Rule 10.14.1.

Accordingly, this Resolution 9 seeks Shareholder approval for the proposed issue of 5,555,104 Plan Options to Mr Dunstan pursuant to ASX Listing Rule 10.14. To understand the effect of passing this Resolution, please see Annexure 4. If this Resolution is not passed, no Plan Options will be issued to Mr Dunstan.

Details of any Plan Options will be published in the annual report of the Company relating to the period in which they were issued, along with a statement that approval for the issue was obtained under ASX Listing Rule 10.14. Any additional persons covered by ASX Listing Rule 10.14 who become entitled to participate in the IOP after this Resolution 9 is approved and who are not named in this Notice will not participate until approval is obtained under that rule.

9.3 Approval for the purposes of Chapter 2E of the Corporations Act not sought

Please refer to section 2.3 for an understanding of the law regarding Related Party transactions.

27

Legal/74543857_36

Due to the broad meaning of 'financial benefit' under the Corporations Act, the issue of Plan Options to Mr Dunstan is likely to constitute giving a financial benefit to a Related Party of the Company for the purposes of Chapter 2E of the Corporations Act.

The Directors are of the view that the giving of the financial benefit to Mr Dunstan as a Related Party of the Company is reasonable remuneration and falls within the exception in section 211 of the Corporations Act.

Accordingly, Shareholder approval for the purposes of Chapter 2E is not being sought.

9.4 Shareholder approval under ASX Listing Rule 10.11 not sought

Exception 8 to ASX Listing Rule 10.12 provides that if Shareholder approval for a transaction is being obtained pursuant to ASX Listing Rule 10.14, approval is not required under ASX Listing Rule 10.11. Therefore, Shareholder approval is not being sought for the approval of this Resolution.

9.5 Shareholder approval under ASX Listing Rule 7.1 not sought

Exception 14 to ASX Listing Rule 7.2 provides that if Shareholder approval for a transaction is being obtained pursuant to ASX Listing Rule 10.14, approval is not required under ASX Listing Rule 7.1. Therefore, Shareholder approval is not being sought for the approval of this Resolution.

9.6 Required Information

Pursuant to ASX Listing Rule 10.15 the following information is provided.

Person to whom the Securities are to
be issued, number and class
Mr Dunstan is to be issued 5,555,104
Plan Options.
Current remuneration package $255,000 cash per annum plus Options
valued at $120,000 plus statutory
superannuation.
Securities previously issued under the
scheme and price paid for those
Securities
5,325,284 Plan Options have previously
been issued to Mr Dunstan. The
average price paid by Mr Dunstan to
acquire these Plan Options was $0.00
per Plan Option.
Terms of the Securities Terms of the Plan Options issued to Mr
Dunstan are contained in Annexure 2.
Reasoning behind the type of Security The Company believes the grant of
Options as opposed to Shares are
preferable as Options will vest upon
the satisfaction of certain conditions.
This helps align the Company and Mr
Dunstan's long-term goals and vision.
Price and value of the Securities $0.03 per Plan Option, being a total
value of $73,369 based on a Black and
Scholes valuation with an implied
volatility of 30%. For the avoidance of

28

Legal/74543857_36

doubt, Mr Dunstan will not be required
to pay any consideration to receive
the 5,555,104 Plan Options the subject
of this Resolution.
Issue date The Shares will be issued within three
years after the date of this Meeting.
Material terms of the scheme Material
terms
of
the
IOP
are
contained in Annexure 3.
Material terms of loan No loan will be given to Mr Dunstan by
the Company to acquire the Plan
Options.

9.7 Board recommendation

The Board, with Mr Dunstan abstaining, recommends that Shareholders vote in favour of Resolution 9.

10. RESOLUTION 10: PROPOSED ISSUE OF PLAN OPTIONS TO MR CHRISTOPHER JOSEPH

10.1 Background

As a Director, Mr Joseph is eligible to participate in the IOP. In recognition of Mr Joseph's performance and to further promote Mr Joseph's engagement with Mobecom, the Company proposes, subject to obtaining Shareholder approval, to issue 1,388,776 Plan Options to Mr Joseph. For the avoidance of doubt, no consideration is payable by Mr Joseph to receive the Plan Options.

As at the date of this Notice, Mr Joseph and his Associates hold 9,669,763 Shares and 1,775,095 Plan Options in the Company. Approval for the purposes of ASX Listing Rule 10.14 is sought

ASX Listing Rule 10.14.1 requires a listed entity to obtain Shareholder approval by ordinary resolution prior to the issue of, or agreement to issue, Securities under an employee incentive scheme to a person who is a related party. Being a Director, Mr Joseph is a related party who falls within the category set out in ASX Listing Rule 10.14.1.

Accordingly, this Resolution 10 seeks Shareholder approval for the proposed issue of 1,388,776 Plan Options to Mr Joseph pursuant to ASX Listing Rule 10.14. To understand the effect of passing this Resolution, please see Annexure 4. If this Resolution is not passed, no Plan Options will be issued to Mr Joseph.

Details of any Plan Options will be published in the annual report of the Company relating to the period in which they were issued, along with a statement that approval for the issue was obtained under ASX Listing Rule 10.14. Any additional persons covered by ASX Listing Rule 10.14 who become entitled to participate in the IOP after this Resolution 10 is approved and who are not named in this Notice will not participate until approval is obtained under that rule.

29

Legal/74543857_36

10.2 Approval for the purposes of Chapter 2E of the Corporations Act not sought

Please refer to section 2.3 for an understanding of the law regarding related party transactions.

Due to the broad meaning of 'financial benefit' under the Corporations Act, the issue of Plan Options to Mr Joseph is likely to constitute giving a financial benefit to a Related Party of the Company for the purposes of Chapter 2E of the Corporations Act.

The Directors are of the view that the giving of the financial benefit to Mr Joseph as a Related Party of the Company is for reasonable remuneration and falls within the exception in section 211 of the Corporations Act.

Accordingly, Shareholder approval for the purposes of Chapter 2E is not being sought.

10.3 Shareholder approval under ASX Listing Rule 10.11 not sought

Exception 8 to ASX Listing Rule 10.12 provides that if Shareholder approval for a transaction is being obtained pursuant to ASX Listing Rule 10.14, approval is not required under ASX Listing Rule 10.11. Therefore, Shareholder approval is not being sought for the approval of this Resolution.

10.4 Shareholder approval under ASX Listing Rule 7.1 not sought

Exception 14 to ASX Listing Rule 7.2 provides that if Shareholder approval for a transaction is being obtained pursuant to ASX Listing Rule 10.14, approval is not required under ASX Listing Rule 7.1. Therefore, Shareholder approval is not being sought for the approval of this Resolution.

10.5 Required Information

Pursuant to ASX Listing Rule 10.15 the following information is provided.

Person to whom the Securities are to
be issued, number and class
Mr Joseph is to be issued 1,388,776
Plan Options.
Current remuneration package $240,000
Securities previously issued under the
scheme
1,775,095 Plan Options have previously
been issued to Mr Joseph.
The
average price paid by Mr Joseph to
receive these Option Plans was $0.00
per Plan Option.
Terms of the Securities Terms of the Plan Options issued to Mr
Joseph are contained in Annexure 2.
Reasoning behind the type of Security The Company believes the grant of
Options as opposed to Shares are
preferable as Options will vest upon
the satisfaction of certain conditions.
This helps align the Company and Mr
Joseph's long-term goals and vision.
Price and value of the Securities $0.03 per Plan Option, being a total
value of $19,134 based on a Black and

30

Legal/74543857_36

Scholes valuation_with a_30% implied
volatility. For the avoidance of doubt,
Mr Joseph will not be required to pay
any consideration to receive the
1,388,776 Plan Options the subject of
this Resolution.
Issue date The Shares will be issued within three
years after the date of this Meeting.
Material terms of the scheme Material
terms
of
the
IOP
are
contained in Annexure 3.
Material terms of loan No loan will be given to Mr Joseph by
the Company to acquire the Plan
Options.

10.6 Board recommendation

The Board, with Mr Joseph abstaining, recommends that Shareholders vote in favour of Resolution 10.

11. RESOLUTION 11: PROPOSED ISSUE OF PLAN OPTIONS TO MR BRYAN ZEKULICH

11.1 Background

As a Director, Mr Zekulich is eligible to participate in the IOP. To further promote Mr Zekulich's engagement with the Company, the Company proposes, subject to obtaining Shareholder approval, to issue 1,500,000 Plan Options to Mr Zekulich. For the avoidance of doubt, no consideration is payable by Mr Zekulich to receive the Plan Options.

As at the date of this Notice, Mr Zekulich and his Associates hold Nil Shares and Nil Options in the Company. If Resolution 3 is approved, Mr Zekulich and his Associates will hold 5,000,000 Shares and Nil Options in the Company.

11.2 Approval for the purposes of ASX Listing Rule 10.14 is sought

ASX Listing Rule 10.14.1 requires a listed entity to obtain Shareholder approval by ordinary resolution prior to the issue of, or agreement to issue, Securities under an employee incentive scheme to a person who is a related party. Being a Director, Mr Zekulich is a related party who falls within the category set out in ASX Listing Rule 10.14.1.

Accordingly, this Resolution 11 seeks Shareholder approval for the proposed issue of 1,500,000 Plan Options to Mr Zekulich pursuant to ASX Listing Rule 10.14. To understand the effect of passing this Resolution, please see Annexure 4. If this Resolution is not passed, no Plan Options will be issued to Mr Zekulich.

Details of any Plan Options will be published in the annual report of the Company relating to the period in which they were issued, along with a statement that approval for the issue was obtained under ASX Listing Rule 10.14. Any additional persons covered by ASX Listing Rule 10.14 who become entitled to participate in the IOP after this Resolution 11 is approved and who are not named in this Notice will not participate until approval is obtained under that rule.

31

Legal/74543857_36

11.3 Approval for the purposes of Chapter 2E of the Corporations Act not sought

Please refer to section 2.3 for an understanding of the law regarding related party transactions.

Due to the broad meaning of 'financial benefit' under the Corporations Act, the issue of Plan Options to Mr Zekulich is likely to constitute giving a financial benefit to a Related Party of the Company for the purposes of Chapter 2E of the Corporations Act.

The Directors are of the view that the giving of the financial benefit to Mr Zekulich as a Related Party of the Company is for reasonable remuneration and falls within the exception in section 211 of the Corporations Act.

Accordingly, Shareholder approval for the purposes of Chapter 2E is not being sought.

11.4 Shareholder approval under ASX Listing Rule 10.11 not sought

Exception 8 to ASX Listing Rule 10.12 provides that if Shareholder approval for a transaction is being obtained pursuant to ASX Listing Rule 10.14, approval is not required under ASX Listing Rule 10.11. Therefore, Shareholder approval is not being sought for the approval of this Resolution.

11.5 Shareholder approval under ASX Listing Rule 7.1 not sought

Exception 14 to ASX Listing Rule 7.2 provides that if Shareholder approval for a transaction is being obtained pursuant to ASX Listing Rule 10.14, approval is not required under ASX Listing Rule 7.1. Therefore, Shareholder approval is not being sought for the approval of this Resolution.

11.6 Required Information

Pursuant to ASX Listing Rule 10.15 the following information is provided.

Person to whom the Securities are to
be issued, number and class
Mr Zekulich is to be issued 1,500,000
Plan Options.
Current remuneration package $60,000 p.a. plus statutory super
Securities previously issued under the
scheme
No Plan Options have previously been
issued to Mr Zekulich.
Terms of the Securities Terms of the Plan Options issued to Mr
Zekulich are contained in Annexure 2.
Reasoning behind the type of Security The Company believes the grant of
Options as opposed to Shares are
preferable as Options will vest upon
the satisfaction of certain conditions.
This helps align the Company and Mr
Zekulich's long term goals and vision.
Price and value of the Securities $0.03 per Plan Option, being a total
value of $20,666 based on a Black and
Scholes valuation with an implied
volatility of 30%. For the avoidance of
doubt, Mr Zekulich will not be required

32

Legal/74543857_36

to pay any consideration to receive
the 1,500,000 Plan Options the subject
of this Resolution.
Issue date The Shares will be issued within three
years after the date of this Meeting.
Material terms of the scheme Material
terms
of
the
IOP
are
contained in Annexure 3.
Material terms of loan No loan will be given to Mr Zekulich by
the Company to acquire the Plan
Options.

11.7 Board recommendation

The Board, with Mr Zekulich abstaining, recommends that Shareholders vote in favour of Resolution 11.

12. RESOLUTION 12: PROPOSED ISSUE OF PLAN OPTIONS TO MR MICHAEL HILL

12.1 Background

As a Director, Mr Hill is eligible to participate in the IOP. To further promote Mr Hill's engagement with Mobecom, the Company proposes, subject to obtaining Shareholder approval, to issue 1,500,000 Plan Options to Mr Hill. For the avoidance of doubt, no consideration is payable by Mr Hill to receive the Plan Options.

As at the date of this Notice, Mr Hill and his Associates hold NIL Shares and NIL Options in the Company. If Resolution 4 is approved, Mr Hill and his Associates will hold 2,500,000 Shares and Nil Options in the Company.

12.2 Approval for the purposes of ASX Listing Rule 10.14 is sought

ASX Listing Rule 10.14.1 requires a listed entity to obtain Shareholder approval by ordinary resolution prior to the issue of, or agreement to issue, Securities under an employee incentive scheme to a person who is a related party. Being a Director, Mr Hill is a related party who falls within the category set out in ASX Listing Rule 10.14.1.

Accordingly, this Resolution 12 seeks Shareholder approval for the proposed issue of 1,500,000 Plan Options to Mr Hill pursuant to ASX Listing Rule 10.14. To understand the effect of passing this Resolution, please see Annexure 4. If this Resolution is not passed, no Plan Options will be issued to Mr Hill.

Details of any Plan Options will be published in the annual report of the Company relating to the period in which they were issued, along with a statement that approval for the issue was obtained under ASX Listing Rule 10.14. Any additional persons covered by ASX Listing Rule 10.14 who become entitled to participate in the IOP after this Resolution 12 is approved and who are not named in this Notice will not participate until approval is obtained under that rule.

33

Legal/74543857_36

12.3 Approval for the purposes of Chapter 2E of the Corporations Act not sought

Please refer to section 2.3 for an understanding of the law regarding related party transactions.

Due to the broad meaning of 'financial benefit' under the Corporations Act, the issue of Plan Options to Mr Hill is likely to constitute giving a financial benefit to a Related Party of the Company for the purposes of Chapter 2E of the Corporations Act.

The Directors are of the view that the giving of the financial benefit to Mr Hill as a Related Party of the Company is for reasonable remuneration and falls within the exception in section 211 of the Corporations Act.

Accordingly, Shareholder approval for the purposes of Chapter 2E is not being sought.

12.4 Shareholder approval under ASX Listing Rule 10.11 not sought

Exception 8 to ASX Listing Rule 10.12 provides that if Shareholder approval for a transaction is being obtained pursuant to ASX Listing Rule 10.14, approval is not required under ASX Listing Rule 10.11. Therefore, Shareholder approval is not being sought for the approval of this Resolution.

12.5 Shareholder approval under ASX Listing Rule 7.1 not sought.

Exception 14 to ASX Listing Rule 7.2 provides that if Shareholder approval for a transaction is being obtained pursuant to ASX Listing Rule 10.14, approval is not required under ASX Listing Rule 7.1. Therefore, Shareholder approval is not being sought for the approval of this Resolution.

12.6 Required Information

Pursuant to ASX Listing Rule 10.15 the following information is provided.

Person to whom the Securities are to
be issued, number and class
Mr Hill is to be issued 1,500,000 Plan
Options.
Current remuneration package $60,000 p.a. plus statutory super
Securities previously issued under the
scheme
No Plan Options have previously been
issued to Mr Hill.
Terms of the Securities Terms of the Plan Options issued to Mr
Hill are contained in Annexure 2.
Reasoning behind the type of Security The Company believes the grant of
Options as opposed to Shares are
preferable as Options will vest upon
the satisfaction of certain conditions.
This helps align the Company and Mr
Hill's long-term goals and vision.
Price and value of the Securities $0.03 per Plan Option, being a total
value of $20,666 based on a Black and
Scholes valuation with an implied
volatility of 30%. For the avoidance of
doubt, Mr Hill will not be required to

34

Legal/74543857_36

pay any consideration to receive the
1,500,00 Plan Options the subject of
this Resolution.
Issue date The Shares will be issued within three
years after the date of this Meeting.
Material terms of the scheme Material
terms
of
the
IOP
are
contained in Annexure 3.
Material terms of loan No loan will be given to Mr Hill by the
Company to acquire the Plan Options.

12.7 Board recommendation

The Board, with Mr Hill abstaining, recommends that Shareholders vote in favour of Resolution 12.

13. RESOLUTION 13: APPROVAL FOR ISSUE OF SHARES TO CHRISTOPHER LAWRANCE UPON CONVERSION OF DEBT

13.1 Background

On 9 July 2013 Christopher Lawrance loaned CSB Engage Pte Ltd $243,000 at an interest rate of 7% per annum with the loaned funds to be applied to the CSB Engage Pte Ltd's working capital needs. On 11 October 2017 the Company successfully acquired 100% of the shares in CSB Engage Pte Ltd, receiving the benefit and liability of the loan. This loan was for an initial term of 13 months which would be automatically rolled over for additional 12 month periods unless terminated or called in earlier by the parties. The Company has requested and Mr Lawrance has agreed to, subject to Shareholder approval:

(a) convert the amount owing to Mr Lawrence into Shares at a deemed value of $0.027 per Share; and

(b) forgive any interest which otherwise accrued on the loan.

As at the date of this Notice, Mr Lawrance is not a substantial Shareholder of the Company. Mr Lawrance was previously a substantial Shareholder of the Company.

13.2 Approval for the purposes of ASX Listing Rule 7.1 is sought

As announced on 26 November 2020, the Company has provided an undertaking to the ASX that it will not issue any Equity Securities without Shareholder approval until 13 December 2021, unless the issue of Equity Securities falls within an exception set out in ASX Listing Rule 7.2.

Accordingly, Shareholder approval is sought to approve the issue of Securities upon conversion of debt, to Mr Lawrence. The effect of such approval is that the Company will be entitled to issue 9,000,000 Shares to Mr Lawrance and the Company will discharge its obligations to repay Mr Lawrance. To understand the effect of passing this Resolution, please see Annexure 4.

35

Legal/74543857_36

If this Resolution 13 is not approved, the Company must draw down its cash reserve to pay the debt owing to Mr Lawrance .

13.3 Required information

Pursuant to ASX Listing Rule 7.3 the following information is provided.

Person to whom the Securities are to
be issued, number and class
Mr Lawrance is to be issued 9,000,000
Shares upon conversion of debt.
Issue date The Shares will be issued to Mr
Lawrance within three months after
the date of this Meeting.
Issue price $0.027 per Share.
Terms of the Securities Shares will rank equally in all respects
with the existing fully paid ordinary
Shares.
Purpose of issue and use of funds No funds will be received by the
Company for the issue of Shares to Mr
Lawrance however the issue will set
off the Company's obligation to pay
Mr Lawrance the debt owing to him
in cash.

13.4 Board recommendation

The Board recommends that Shareholders vote in favour of this Resolution 13.

36

Legal/74543857_36

GLOSSARY

AEST means Australian Eastern Standard Time as observed in Sydney, New South Wales.

Annexure means an annexure of this Notice.

ASIC means the Australian Securities and Investments Commission.

Associate has the meaning given to that term in sections 10 to 17 of the Corporations Act.

ASX means ASX Limited or the market operated by it, as the context requires.

ASX Listing Rules means the Listing Rules of the ASX.

Board means the current board of Directors of the Company.

Bombora means Bombora Investment Management Pty Ltd ATF Bombora Special Investments Growth Fund ACN 625 413 390.

Bombora Investment Commitment has the meaning given to that term in section 7.1 of the Notice.

Bombora Loan means the $1,500,000 loan advanced to the Company by Bombora on the terms of the Bombora Loan Agreement.

Bombora Loan Agreement has the meaning given to that term in section 5.1.

Bombora Shares has the meaning given to that term in section 7.1 of the Notice.

Chair means the chair of the Meeting.

Closely Related Party of a member of the Key Management Personnel means:

  • (a) a spouse or child of the member;

  • (b) a child of the member’s spouse;

  • (c)

  • a dependent of the member or the member’s spouse;

  • (d) anyone else who is one of the member’s family and may be expected to influence the member, or be influenced by the member, in the member’s dealing with the entity;

  • (e) a company the member controls; or

  • (f) a person prescribed by the Corporations Regulations 2001 (Cth).

Closing Date has the meaning given to that term in section (j) of Annexure 3.

Company or Mobecom means Mobecom Limited (ACN 125 688 940).

Company Secretary means Mr David Hwang.

Constitution means the Company’s constitution.

Convertible Note means the debt instrument which may be converted to equity on the terms agreed between the convertible note holder and the Company under the Convertible Note Agreement.

Convertible Note Agreement has the meaning given to that term in section 5.2.

Corporations Act means the Corporations Act 2001 (Cth).

Directors means the directors of the Company from time to time.

Eligible Participant has the meaning given to that term in section (a) of Annexure 3.

37

Legal/74543857_36

Equity Securities includes a Share, a right to a Share or Option, an Option, a convertible security and any security that ASX decides to classify as an Equity Security.

Executive Chairman means the executive chairman of the Company.

Expiry Date has the meaning given to that term in section (b)(v) of Annexure 3.

Explanatory Statement means the explanatory statement accompanying the Notice.

General Meeting or Meeting means the meeting convened by the Notice.

GSD has the meaning given to that term in section 5.1.

Incentive Option Plan or IOP means the Company's employee incentive scheme adopted on 1 May 2017 and renewed on 27 November 2020.

Key Management Personnel has the same meaning as in the accounting standards issued by the Australian Accounting Standards Board and means those persons having authority and responsibility for planning, directing and controlling the activities of the Company, or if the Company is part of a consolidated entity, of the consolidated entity, directly or indirectly, including any director (whether executive or otherwise) of the Company, or if the Company is part of a consolidated entity, of an entity within the consolidated group.

Notice or Notice of Meeting means this notice of meeting including the Explanatory Statement and the Proxy Form.

Novus Capital means Novus Capital Limited ACN 006 711 995.

Novus Mandate has the meaning given to that term in section 6.1 of the Notice.

Novus Shares has the meaning given to that term in section 6.1 of the Notice.

Offer has the meaning given to that term in section (b) of Annexure 3.

Option means an option to subscribe for a Share, including Plan Options.

Plan Options means an Option issued under the IOP.

Proxy Form means the proxy form accompanying the Notice.

Related Party as defined in section 228 of the Corporations Act and Chapter 19 of the ASX Listing Rules.

Resolution means a resolution set out in the Notice.

Securities as defined in Chapter 19 of the ASX Listing Rules.

Share means a fully paid ordinary share in the capital of the Company.

Shareholder means a holder of a Share.

38

Legal/74543857_36

Annexure 1

Proxy Form

39

Legal/74543857_36

==> picture [205 x 96] intentionally omitted <==

All Correspondence to:

  • By Mail Boardroom Pty Limited GPO Box 3993 Sydney NSW 2001 Australia

  • By Fax: +61 2 9290 9655  Online: www.boardroomlimited.com.au

  • By Phone: (within Australia) 1300 737 760 (outside Australia) +61 2 9290 9600

YOUR VOTE IS IMPORTANT

For your vote to be effective it must be recorded before 4.00pm (AEST) on Sunday, 9 May 2021.

TO VOTE ONLINE BY SMARTPHONE STEP 1: VISIT https://www.votingonline.com.au/mbmgm2021 STEP 2: Enter your Postcode OR Country of Residence (if outside Australia) STEP 3: Enter your Voting Access Code (VAC):

Scan QR Code

using smartphone

QR Reader App

TO VOTE BY COMPLETING THE PROXY FORM

STEP 1 APPOINTMENT OF PROXY

Indicate who you want to appoint as your Proxy.

If you wish to appoint the Chair of the Meeting as your proxy, mark the box. If you wish to appoint someone other than the Chair of the Meeting as your proxy please write the full name of that individual or body corporate. If you leave this section blank, or your named proxy does not attend the meeting, the Chair of the Meeting will be your proxy. A proxy need not be a securityholder of the company. Do not write the name of the issuer company or the registered securityholder in the space.

Appointment of a Second Proxy

You are entitled to appoint up to two proxies to attend the meeting and vote. If you wish to appoint a second proxy, an additional Proxy Form may be obtained by contacting the company’s securities registry or you may copy this form.

STEP 3 SIGN THE FORM

The form must be signed as follows: Individual: This form is to be signed by the securityholder.

Joint Holding : where the holding is in more than one name, all the securityholders should sign.

Power of Attorney: to sign under a Power of Attorney, you must have already lodged it with the registry. Alternatively, attach a certified photocopy of the Power of Attorney to this form when you return it.

Companies: this form must be signed by a Director jointly with either another Director or a Company Secretary. Where the company has a Sole Director who is also the Sole Company Secretary, this form should be signed by that person. Please indicate the office held by signing in the appropriate place.

STEP 4 LODGEMENT

To appoint a second proxy you must:

(a) complete two Proxy Forms. On each Proxy Form state the percentage of your voting rights or the number of securities applicable to that form. If the appointments do not specify the percentage or number of votes that each proxy may exercise, each proxy may exercise half your votes. Fractions of votes will be disregarded. (b) return both forms together in the same envelope.

STEP 2 VOTING DIRECTIONS TO YOUR PROXY

To direct your proxy how to vote, mark one of the boxes opposite each item of business. All your securities will be voted in accordance with such a direction unless you indicate only a portion of securities are to be voted on any item by inserting the percentage or number that you wish to vote in the appropriate box or boxes. If you do not mark any of the boxes on a given item, your proxy may vote as he or she chooses. If you mark more than one box on an item for all your securities your vote on that item will be invalid.

Proxy which is a Body Corporate

Where a body corporate is appointed as your proxy, the representative of that body corporate attending the meeting must have provided an “Appointment of Corporate Representative” prior to admission. An Appointment of Corporate Representative form can be obtained from the company’s securities registry.

Proxy forms (and any Power of Attorney under which it is signed) must be received no later than 48 hours before the commencement of the meeting, therefore by 4.00pm (AEST) on Sunday 9 May 2021. Any Proxy Form received after that time will not be valid for the scheduled meeting.

Proxy forms may be lodged using the enclosed Reply Paid Envelope or:

Online https://www.votingonline.com.au/mbmgm2021  By Fax + 61 2 9290 9655  By Mail Boardroom Pty Limited GPO Box 3993, Sydney NSW 2001 Australia  In Person Boardroom Pty Limited Level 12, 225 George Street, Sydney NSW 2000 Australia

Attending the Meeting

If you wish to attend the meeting please bring this form with you to assist registration .

40

Legal/74543857_36

Mobecom ACN 125 688 940

Limited

Your Address

This is your address as it appears on the company’s share register. If this is incorrect, please mark the box with an “X” and make the correction in the space to the left. Securityholders sponsored by a broker should advise their broker of any changes.

Please note, you cannot change ownership of your securities using this form.

PROXY FORM

STEP 1 APPOINT A PROXY

I/We being a member/s of Mobecom Limited (Company) and entitled to attend and vote hereby appoint:

the Chair of the Meeting (mark box)

OR if you are NOT appointing the Chair of the Meeting as your proxy, please write the name of the person or body corporate (excluding the registered securityholder) you are appointing as your proxy below

or failing the individual or body corporate named, or if no individual or body corporate is named, the Chair of the Meeting as my/our proxy at the General Meeting of the Company to be held at the Novus Capital, Level 11, 95 Pitt St, Sydney, New South Wales 2000 on Tuesday 11 May 2021 at 4:00pm (AEST) and at any adjournment of that meeting, to act on my/our behalf and to vote in accordance with the following directions or if no directions have been given, as the proxy sees fit.

Chair of the Meeting authorised to exercise undirected proxies on remuneration related matters: If I/we have appointed the Chair of the Meeting as my/our proxy or the Chair of the Meeting becomes my/our proxy by default and I/we have not directed my/our proxy how to vote in respect of Resolutions 2 - 4 and 8 - 12, I/we expressly authorise the Chair of the Meeting to exercise my/our proxy in respect of this/these Resolutions even though Resolutions 2 - 4 and 8 - 12 are connected with the remuneration of a member of the key management personnel for the Company.

The Chair of the Meeting will vote all undirected proxies in favour of all Items of business (including Resolutions 2 - 4 and 8 - 12) If you wish to appoint the Chair of the Meeting as your proxy with a direction to vote against, or to abstain from voting on an item, you must provide a direction by marking the 'Against' or 'Abstain' box opposite that resolution STEP 2 VOTING DIRECTIONS * If you mark the Abstain box for a particular item, you are directing your proxy not to vote on your behalf on a show of hands or on a poll and your vote will not be counted in calculating the required majority if a poll is called.

FOR AGAINST ABSTAIN* AGAINST ABSTAIN* AGAINST ABSTAIN* FOR AGAINST ABSTAIN* AGAINST ABSTAIN*
Res 1 Change of Company Name Res 8 Approval for Proposed Issue of Shares to
Mr Neil Joseph in lieu of unpaid Directors
Fees
Res 2 Approval for Issue of Shares to Mr Iain Res 9 Proposed Issue of Plan Options to Mr Iain
Dunstan Dunstan
Res 3 Approval for Issue of Shares to Mr Bryan Res 10 Proposed Issue of Plan Options to Mr
Zekulich Christopher Joseph
Res 4 Approval for Issue Shares to Mr Michael Hill Res 11 Proposed Issue of Plan Options to Mr
Bryan Zekulich
Res 5 Approval of Issue of Convertible Notes to Res 12 Proposed Issue of Plan Options to Mr
Bombora Michael Hill
Res 6 Approval for Issue of Shares to Novus Capital Res 13 Approval for Issue of Shares to
Christopher Lawrance upon conversion of
Debt
Res 7 Approval for Proposed Issue of Shares to
Bombora

STEP 3 SIGNATURE OF SECURITYHOLDERS This form must be signed to enable your directions to be implemented.

Individual or Securityholder 1 Securityholder 2

Securityholder 3

Sole Director and Sole Company Secretary

Director

Director / Company Secretary

Legal/74543857_36

Contact Name…………………………………………….... Contact Daytime Telephone………………………................................ Date / / 2021

Annexure 2

Terms of Plan Options

The Plan Options the subject of Resolution 9 to Mr Dunstan, Resolution 10 to Mr Joseph, Resolution 11 to Mr Zekulich and Resolution 12 to Mr Hill will be issued on the following material terms:

Plan Options Detail
Vesting Conditions (a)
20% of each Directors' Plan Options will vest should the
Company achieve a revenue target of $3,420,518 for the
financial year ending 30 June 2021;
(b)
A further 40% of each Directors' Plan Options will vest should
the Company achieve a revenue target of $7,056,384 for the
financial year ending 30 June 2022;
(c)
The final 40% of each Directors' Plan Options will vest should
the Company achieve a revenue target of $9,381,210 for the
financial year ending 30 June 2023,
where revenue is based on current operations only exclusive of any
research and development rebates, grants or similar.
Exercise price $0.03 per Option Plan.
Entitlement
on
exercise
1 Share per Plan Option.
Expiry date 13 February 2024
Period of exercise All Plan Options must be exercised by the expiry date. Any Plan
Options which have not been exercised will lapse.
How to exercise a
Plan Option
The holder of aPlan Optioncan exercise their PlanOptionby delivering
a duly completed notice to the Company before the expiry date.
Ranking Shares obtained from the exercise of a PlanOptionwill rank equally with
all existing Shares.
Quotation The Company will not seek quotation of the Plan Options.
Transferability ThePlan Optionsare not transferable.
Reconstruction
of
capital
If at any time the issued capital of the Company is reconstructed
(including consolidation, subdivision, reduction of return), all rights of
a holder of Plan Options are to be changed to the extent necessary
in a manner consistent with the Corporations Act and the ASX Listing
Rules at the time of the reconstruction.
Participation in new
issues
There are no participation rights or entitlements inherent in the Plan
Options and holders of Plan Options will not be entitled to participate
in new issues of capital offered to Shareholders during the currency
of the Plan Options without exercising the Plan Options. Holders of
these Plan Options will be afforded the period of at least 5 Business
Days prior to and inclusive of the record date (to determine
entitlements to the new issue) to exercise their Plan Options.
Change in Exercise
price/number
of
If there is a bonus issue to Shareholders, the number of ordinary
Shares over which a Plan Option is exercisable may be increased
bythenumberofShareswhich theholderof thePlanOption would

Legal/74543857_36

Plan Options Detail
underlying
ordinary
Shares
have received if Plan Option had been exercised before the
record date for the bonus issue.
In the event that a pro rata issue (except a bonus issue) is made to
Shareholders, the exercise price of the Plan Options may be reduced
in accordance with ASX Listing Rule 6.22.2.

Legal/74543857_36

Annexure 3

Material Terms of the IOP

A summary of the terms of the IOP is set out below. The full terms and conditions of the IOP may be obtained free of charge by contacting the Company Secretary.

  • (a) Eligibility and grant of Options: Options may be granted at the discretion of the Board to any Director, contractor, full time, part time or casual employee of the Company or related body corporate ( Eligible Participant ).

  • (a) Invitation to apply for Options: the Board may provide a written invitation to the Eligible Participant to apply for Options upon the terms set out in the Incentive Option Plan and upon such additional terms and conditions the Board determines ( Offer ). The invitation must specify:

  • (i) the maximum number of Options that the Eligible Participant may apply for, or the formula for determining the maximum number of Options that may be applied for;

  • (ii) the maximum number of Shares that the Eligible Participant is entitled to be issued on the exercise of each Option or the formula for determining the maximum number of Shares;

  • (iii) any application vesting conditions;

  • (iv) any restriction period applied by the Incentive Option Plan or that the Board has resolved to apply to Shares issued on exercise of the Options;

  • (v) the expiry date of the Options ( Expiry Date );

  • (vi) the date by which an application for Options must be received by the Company; and

  • (vii) any other information required by law or the ASX Listing Rules.

  • (b) Number of Options offered: the number of Options which an Eligible Participant is invited to apply for pursuant to an Offer is within the discretion of the Directors. Each Option will, upon exercise of a vested Option, entitle the holder to receive, at the absolute discretion of the Board, either one (1) Share in the capital of the Company, or a cash payment of equivalent value.

  • (c) Cashless Exercise Facility: subject to Board approval, an Eligible Participant may set-off the Option exercise price (if any) against the number of Shares which the Eligible Participant is potentially entitled to receive upon exercise of the Options. The Eligible Participant will then receive, at the absolute discretion of the Board, either Shares or a cash payment to the value of the surplus after the Option exercise price has been set-off.

  • (d) Vesting conditions: an Option may be made subject to vesting conditions as determined by the Board in its discretion and as specified in the Offer for the Option.

  • (e) Option exercise price: subject to any minimum price required by the ASX Listing Rules, the Board may determine the exercise price (if any) for an Option the subject of an Offer in its absolute discretion.

  • (f) Consideration: Options issued under the Incentive Option Plan will be issued for no more than nominal cash consideration.

Legal/74543857_36

  • (g) Escrow: a Share issued on exercise of any Option may be subject to a restriction period.

  • (h) Quotation: Options will not be quoted on the ASX.

  • (i) Lapse of Offer: to the extent that an application for Options is not received by the Company by a specified date ( Closing Date ), the Offer will lapse on the date following the Closing Date.

  • (j) Shares allotted upon exercise of Options: the Company will issue or transfer Shares, or make a cash payment, to the Eligible Participant, within 5 days of receipt of a valid notice of exercise of vested Options. The Shares allotted under the Incentive Option Plan will be of the same class and will rank equally with Shares in the Company at the date of issue. The Company will seek listing of the new Shares on the ASX within the time required by the ASX Listing Rules.

  • (k) Transfer of Options: an Option is non-transferable other than in special circumstances (if the holder suffers death or total and permanent disability, retirement, redundancy, severe financial hardship, or other circumstances determined in the Board's discretion or specified in the relevant Offer) with the consent of the Board. Options are otherwise transferable on the holder's death to their legal personal representative or upon the holder's bankruptcy to their trustee in bankruptcy.

  • (l) Lapse of Options: an Option shall lapse when:

  • (i) an unauthorised dealing in the Option occurs, or the holding engages in fraud, dishonesty or other improper behaviour;

  • (ii) a vesting condition in relation to the Option is not satisfied by the due date, or becomes incapable of satisfaction;

  • (iii) in respect of an unvested Option only, the relevant person ceases to be an Eligible Participant, subject to the Board's discretion to waive the lapsing of the Options in special circumstances;

  • (iv) in respect of a vest Option only, a relevant person ceases to be an Eligible Participant and the Board resolves that the Options granted in respect of that relevant person must:

    • (A) be exercised within a specific period, and the Option is not exercised within that period; or

    • (B) be cancelled by the Company in consideration for a cash payment to the Eligible Participant, and a cash payment is made;

  • (v) the Company undergoes a change of control or a winding up resolution order is made; or

  • (vi) the Option has not been exercised by the Expiry Date.

  • (m) Change of control: If a company obtains control of the Company the vesting conditions are deemed to be automatically waived.

  • (n) Capital reconstruction: in the event of a capital reconstruction, the exercise price and/or number of Options will change to the extent necessary to comply with the ASX Listing Rules applying to a reorganisation of capital at the time of the reorganisation.

Legal/74543857_36

  • (O) Participation in new issues: there are no participating rights or entitlement inherent in the Options and the holders will not be entitled to participate in new Shares offered to Shareholders during the currency of the Options without first exercising the Options. In addition, holders of Options will not be entitled to vote or receive dividends as a result of their holding of Options.

Legal/74543857_36

Annexure 4

Total Dilution

As at the date of this Notice, the Company has on issue 565,634,090 Shares on an undiluted basis and 635,548,901 Securities on a fully diluted basis.

Reso
lution
Recipient of
Securities
Securities the
subject of the
Resolution
**Current Securityholding1 ** **Current Securityholding1 ** New Securityholding if
Resolution is passed
New Securityholding if
Resolution is passed
New %
Security-
holding2
Total dilution if
Resolution is
**passed3 **
2 Iain Dunstan 5,000,000 Shares 787,491 Shares 5,787,491 Shares 2.97% 0.78% dilution
13,256,195 Options 13,256,195 Options
TOTAL:14,043,686 Securities TOTAL:19,043,686 Securities
3 Bryan Zekulich 5,000,000 Shares 0 Securities 5,000,000 Shares 0.78% 0.78% dilution
4 Michael Hill 2,500,000 Shares 0 Securities 2,500,000 Shares 0.39% 0.39% dilution
5 Bombora 10 Convertible
Notes3
24,000,000 Shares 24,000,000 Shares 13.93% 10.56% dilution
10 Convertible Notes4
TOTAL:99,000,000 Securities5
6 Novus Capital 12,000,000 Shares 400,000 Shares 12,400,000 Shares 2.5% 1.85% dilution
3,500,000 Options 3,500,000 Options
TOTAL:3,900,000 Securities TOTAL:15,900,000 Securities
7 Bombora 4,000,000 Shares If
Resolution
5 is not
passed:
24,000,000 Shares If
Resolution
5 is not
passed:
28,000,000 Shares 4.38% (If
Resolution
5 is not
passed)
0.63% dilution
If
Resolution
5 is passed:
24,000,000 Shares If
Resolution
28,000,000 Shares
10 Convertible
Notes
10 Convertible
Notes
16.11% (If
Resolution

Legal/74543857_36

Reso
lution
Recipient of
Securities
Securities the
subject of the
Resolution
**Current Securityholding1 ** **Current Securityholding1 ** New Securityholding if
Resolution is passed
New Securityholding if
Resolution is passed
New %
Security-
holding2
Total dilution if
Resolution is
**passed3 **
TOTAL:99,000,000
Securities5
5 is
passed:
TOTAL:103,000,000
Securities5
5 is
passed)
8 Neil Joseph 5,791,000 Shares 27,434,307 Shares 33,225,307 Shares 5.18% 0.90% dilution
9 Iain Dunstan 5,555,104 Plan
Options
If
Resolution
2 is not
passed:
787,491 Shares If
Resolution
2 is not
passed:
787,491 Shares 3.06% (if
Resolution
2 is not
passed)
0.87% dilution
13,256,195
Options
18,811,299 Options
TOTAL:14,043,686
Securities
TOTAL:19,598,790
Securities6
If
Resolution
2 is passed:
5,787,491 Shares If
Resolution
2 is
passed:
5,787,491 Shares 3.84% (If
Resolution
2 is
passed)
13,256,195
Options
18,811,299 Options
TOTAL:19,043,686
Securities
TOTAL:24,598,790
Securities
10 Christopher
Joseph
1,388,776 Plan
Options
9,669,763 Shares 9,669,763 Shares 2.01% 0.22% dilution
1,775,095 Plan Options 3,163,871 Plan Options
TOTAL:11,444,858 Securities TOTAL:12,833,634 Securities
11 Bryan Zekulich 1,500,000 Plan
Options
If
Resolution
3 is not
passed:
0 Securities If
Resolution
3 is not
passed:
1,500,000 Plan
Options
0.24% (If
Resolution
3 is not
passed)
0.24% dilution
If
Resolution
3 is Passed:
5,000,000 Shares If
Resolution
5,000,000 Shares
1,500,000 Plan
Options
1.02% (If
Resolution

Legal/74543857_36

Reso
lution
Recipient of
Securities
Securities the
subject of the
Resolution
**Current Securityholding1 ** **Current Securityholding1 ** New Securityholding if
Resolution is passed
New Securityholding if
Resolution is passed
New %
Security-
holding2
Total dilution if
Resolution is
**passed3 **
3 is
Passed:
TOTAL:6,500,000
Securities
3 is
passed)
12 Michael Hill 1,500,000 Plan
Options
If
Resolution
4 is not
passed:
0 Securities If
Resolution
4 is not
passed:
1,500,000 Plan
Options
0.24% (If
Resolution
4 is not
passed)
0.24% dilution
If
Resolution
4 is Passed:
2,500,000 Shares If
Resolution
4 is
Passed:
2,500,000 Shares 0.63% (If
Resolution
4 is
passed)
1,500,000 Plan
Options
TOTAL:4,000,000
Securities
13 Christopher
Lawrance
9,000,000 Shares 19,172,424 Shares 28,172,424 Shares 4.37% 1.40% dilution
Total dilution of Shareholders if all Resolutions are passed 20.8% dilution
  • 1 Including all Securities held by that recipient's Associates as at the date of this Notice.

  • 2 This is the total Securityholding of the recipient of Securities on a fully diluted basis if the Resolution is passed

3 This is calculated on a fully diluted basis, assuming all Options and convertible securities will be exercised or converted to Shares. This is also the total dilution of Shareholders if that Resolution only is passed.

4 Refer to Resolution 5 for further details. Each Convertible Note has a face value of $150,000 and is convertible into that number of Shares which is equal to the face value divided by $0.02

5 This is calculated on a fully diluted basis, assuming all Convertible Notes will be converted to Shares.

Legal/74543857_36

==> picture [210 x 96] intentionally omitted <==

All Correspondence to:

  • By Mail Boardroom Pty Limited GPO Box 3993 Sydney NSW 2001 Australia

By Fax: +61 2 9290 9655  Online: www.boardroomlimited.com.au  By Phone: (within Australia) 1300 737 760 (outside Australia) +61 2 9290 9600

YOUR VOTE IS IMPORTANT

For your vote to be effective it must be recorded before 4.00pm (AEST) on Sunday, 9 May 2021.

TO VOTE ONLINE

STEP 1: VISIT https://www.votingonline.com.au/mbmgm2021 STEP 2: Enter your Postcode OR Country of Residence (if outside Australia) STEP 3: Enter your Voting Access Code (VAC):

==> picture [15 x 15] intentionally omitted <==

BY SMARTPHONE

==> picture [62 x 63] intentionally omitted <==

Scan QR Code using smartphone QR Reader App

TO VOTE BY COMPLETING THE PROXY FORM

STEP 1 APPOINTMENT OF PROXY

Indicate who you want to appoint as your Proxy.

If you wish to appoint the Chair of the Meeting as your proxy, mark the box. If you wish to appoint someone other than the Chair of the Meeting as your proxy please write the full name of that individual or body corporate. If you leave this section blank, or your named proxy does not attend the meeting, the Chair of the Meeting will be your proxy. A proxy need not be a securityholder of the company. Do not write the name of the issuer company or the registered securityholder in the space.

Appointment of a Second Proxy

You are entitled to appoint up to two proxies to attend the meeting and vote. If you wish to appoint a second proxy, an additional Proxy Form may be obtained by contacting the company’s securities registry or you may copy this form.

STEP 3 SIGN THE FORM

The form must be signed as follows:

Individual: This form is to be signed by the securityholder.

Joint Holding : where the holding is in more than one name, all the securityholders should sign.

Power of Attorney: to sign under a Power of Attorney, you must have already lodged it with the registry. Alternatively, attach a certified photocopy of the Power of Attorney to this form when you return it.

Companies: this form must be signed by a Director jointly with either another Director or a Company Secretary. Where the company has a Sole Director who is also the Sole Company Secretary, this form should be signed by that person. Please indicate the office held by signing in the appropriate place.

STEP 4 LODGEMENT

To appoint a second proxy you must:

(a) complete two Proxy Forms. On each Proxy Form state the percentage of your voting rights or the number of securities applicable to that form. If the appointments do not specify the percentage or number of votes that each proxy may exercise, each proxy may exercise half your votes. Fractions of votes will be disregarded.

(b) return both forms together in the same envelope.

STEP 2 VOTING DIRECTIONS TO YOUR PROXY

To direct your proxy how to vote, mark one of the boxes opposite each item of business. All your securities will be voted in accordance with such a direction unless you indicate only a portion of securities are to be voted on any item by inserting the percentage or number that you wish to vote in the appropriate box or boxes. If you do not mark any of the boxes on a given item, your proxy may vote as he or she chooses. If you mark more than one box on an item for all your securities your vote on that item will be invalid.

Proxy which is a Body Corporate

Where a body corporate is appointed as your proxy, the representative of that body corporate attending the meeting must have provided an “Appointment of Corporate Representative” prior to admission. An Appointment of Corporate Representative form can be obtained from the company’s securities registry.

Proxy forms (and any Power of Attorney under which it is signed) must be received no later than 48 hours before the commencement of the meeting, therefore by 4.00pm (AE S T) on Sunday 9 May 2021. Any Proxy Form received after that time will not be valid for the scheduled meeting.

Proxy forms may be lodged using the enclosed Reply Paid Envelope or:

Online https://www.votingonline.com.au/mbmgm2021  By Fax + 61 2 9290 9655  By Mail Boardroom Pty Limited GPO Box 3993, Sydney NSW 2001 Australia  In Person Boardroom Pty Limited Level 12, 225 George Street, Sydney NSW 2000 Australia

Attending the Meeting

If you wish to attend the meeting please bring this form with you to assist registration .

Mobecom Limited ACN 125 688 940

Your Address

This is your address as it appears on the company’s share register. If this is incorrect, please mark the box with an “X” and make the correction in the space to the left. Securityholders sponsored by a broker should advise their broker of any changes. Please note, you cannot change ownership of your securities using this form.

PROXY FORM

STEP 1 APPOINT A PROXY

I/We being a member/s of Mobecom Limited (Company) and entitled to attend and vote hereby appoint:

the Chair of the Meeting (mark box)

OR if you are NOT appointing the Chair of the Meeting as your proxy, please write the name of the person or body corporate (excluding the registered securityholder) you are appointing as your proxy below

or failing the individual or body corporate named, or if no individual or body corporate is named, the Chair of the Meeting as my/our proxy at the General Meeting of the Company to be held at the Novus Capital, Level 11, 95 Pitt St, Sydney, New South Wales 2000 on Tuesday 11 May 2021 at 4:00pm (AEST) and at any adjournment of that meeting, to act on my/our behalf and to vote in accordance with the following directions or if no directions have been given, as the proxy sees fit.

Chair of the Meeting authorised to exercise undirected proxies on remuneration related matters: If I/we have appointed the Chair of the Meeting as my/our proxy or the Chair of the Meeting becomes my/our proxy by default and I/we have not directed my/our proxy how to vote in respect of Resolutions 2 - 4 and 8 - 12, I/we expressly authorise the Chair of the Meeting to exercise my/our proxy in respect of this/these Resolutions even though Resolutions 2 - 4 and 8 - 12 are connected with the remuneration of a member of the key management personnel for the Company.

The Chair of the Meeting will vote all undirected proxies in favour of all Items of business (including Resolutions 2 - 4 and 8 - 12) If you wish to appoint the Chair of the Meeting as your proxy with a direction to vote against, or to abstain from voting on an item, you must provide a direction by marking the 'Against' or 'Abstain' box opposite that resolution STEP 2 VOTING DIRECTIONS * If you mark the Abstain box for a particular item, you are directing your proxy not to vote on your behalf on a show of hands or on a poll and your vote will not be counted in calculating the required majority if a poll is called.

FOR AGAINST ABSTAIN* AGAINST ABSTAIN* AGAINST ABSTAIN* FOR AGAINST ABSTAIN* AGAINST ABSTAIN*
Res 1 Change of Company Name Res 8 Approval for Proposed Issue of Shares to
Mr Neil Joseph in lieu of unpaid Directors
Fees
Res 2 Approval for Issue of Shares to Mr Iain Res 9 Proposed Issue of Plan Options to Mr
Dunstan Iain Dunstan
Res 3 Approval for Issue of Shares to Mr Bryan Res 10 Proposed Issue of Plan Options to Mr
Zekulich Christopher Joseph
Res 4 Approval for Issue Shares to Mr Michael Hill Res 11 Proposed Issue of Plan Options to Mr
Bryan Zekulich
Res 5 Approval of Issue of Convertible Notes to Res 12 Proposed Issue of Plan Options to Mr
Bombora Michael Hill
Res 6 Approval for Issue of Shares to Novus Res 13 Approval for Issue of Shares to
Capital Christopher Lawrance upon conversion
of Debt
Res 7 Approval for Proposed Issue of Shares to
Bombora

STEP 3 SIGNATURE OF SECURITYHOLDERS This form must be signed to enable your directions to be implemented.

Individual or Securityholder 1 Securityholder 2 Sole Director and Sole Company Secretary Director

Securityholder 3

Director / Company Secretary

Contact Name…………………………………………….... Contact Daytime Telephone………………………................................ Date / / 2021